β-Cyclodextrin Nanosponges for Oral Drug Delivery of Anti-Hypertensive Drug
Nicardipine (NC) is an antihypertensive drug indicated for treatment of high blood pressure and angina. It belongs to BCS class-II, having poor solubility and low oral bioavailability. The present work was aimed at developing pyromellitic dianhydride (PMDA) cross-linked β-cyclodextrin (βCD) nanospon...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-11-01
|
| Series: | Medical Sciences Forum |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2673-9992/14/1/41 |
| _version_ | 1797609858293301248 |
|---|---|
| author | Ritika Prashant Khivansara Sandhya Bajirao Jadhav Varsha Daund Atul Sherje |
| author_facet | Ritika Prashant Khivansara Sandhya Bajirao Jadhav Varsha Daund Atul Sherje |
| author_sort | Ritika Prashant Khivansara |
| collection | DOAJ |
| description | Nicardipine (NC) is an antihypertensive drug indicated for treatment of high blood pressure and angina. It belongs to BCS class-II, having poor solubility and low oral bioavailability. The present work was aimed at developing pyromellitic dianhydride (PMDA) cross-linked β-cyclodextrin (βCD) nanosponges (NS) for improved solubility and drug release. The βCDNS were prepared by the solvent evaporation method in 1:2, 1:4, 1:6 <i>w</i>/<i>w</i> ratio of β-CD: PMDA. The prepared drug loaded β-CDNS were subjected to characterization studies such as DSC, FESEM, FTIR, PXRD and particle size. Characterisation studies confirmed the formation of nanosponges and the entrapment of drug molecules into them. The βCDNS prepared in 1:4 <i>w</i>/<i>w</i> ratio of βCD: PMDA showed the highest increase in solubility and entrapment efficiency, with particle size of 411 nm and −20.9 mV zeta potential. The molecular docking study revealed the formation of stable complexes through interaction of NC and βCD. The nanosponges were formulated into a capsule dosage form by blending the drug-loaded nanosponges with granulated excipients such as talc, aerosol, lactose and starch. The powder blend showed acceptable flow properties. The in vitro dissolution studies of the optimized capsule formulation, performed using USP Type-I apparatus, showed considerably higher drug release compared to pure NC. Thus, PMDA cross-linked βCDNS represents a novel approach to solubility enhancement and an improved dissolution of the selected model drug. |
| first_indexed | 2024-03-11T06:06:14Z |
| format | Article |
| id | doaj.art-7737d08474404425b6ebe0401c9fcedf |
| institution | Directory Open Access Journal |
| issn | 2673-9992 |
| language | English |
| last_indexed | 2024-03-11T06:06:14Z |
| publishDate | 2022-11-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Medical Sciences Forum |
| spelling | doaj.art-7737d08474404425b6ebe0401c9fcedf2023-11-17T12:57:20ZengMDPI AGMedical Sciences Forum2673-99922022-11-011414110.3390/ECMC2022-13240β-Cyclodextrin Nanosponges for Oral Drug Delivery of Anti-Hypertensive DrugRitika Prashant Khivansara0Sandhya Bajirao Jadhav1Varsha Daund2Atul Sherje3Dr. Bhanuben Nanavati College of Pharmacy, Mumbai 400056, IndiaDr. Bhanuben Nanavati College of Pharmacy, Mumbai 400056, IndiaDr. Bhanuben Nanavati College of Pharmacy, Mumbai 400056, IndiaDr. Bhanuben Nanavati College of Pharmacy, Mumbai 400056, IndiaNicardipine (NC) is an antihypertensive drug indicated for treatment of high blood pressure and angina. It belongs to BCS class-II, having poor solubility and low oral bioavailability. The present work was aimed at developing pyromellitic dianhydride (PMDA) cross-linked β-cyclodextrin (βCD) nanosponges (NS) for improved solubility and drug release. The βCDNS were prepared by the solvent evaporation method in 1:2, 1:4, 1:6 <i>w</i>/<i>w</i> ratio of β-CD: PMDA. The prepared drug loaded β-CDNS were subjected to characterization studies such as DSC, FESEM, FTIR, PXRD and particle size. Characterisation studies confirmed the formation of nanosponges and the entrapment of drug molecules into them. The βCDNS prepared in 1:4 <i>w</i>/<i>w</i> ratio of βCD: PMDA showed the highest increase in solubility and entrapment efficiency, with particle size of 411 nm and −20.9 mV zeta potential. The molecular docking study revealed the formation of stable complexes through interaction of NC and βCD. The nanosponges were formulated into a capsule dosage form by blending the drug-loaded nanosponges with granulated excipients such as talc, aerosol, lactose and starch. The powder blend showed acceptable flow properties. The in vitro dissolution studies of the optimized capsule formulation, performed using USP Type-I apparatus, showed considerably higher drug release compared to pure NC. Thus, PMDA cross-linked βCDNS represents a novel approach to solubility enhancement and an improved dissolution of the selected model drug.https://www.mdpi.com/2673-9992/14/1/41β-cyclodextrinnanospongesantihypertensivesolubility |
| spellingShingle | Ritika Prashant Khivansara Sandhya Bajirao Jadhav Varsha Daund Atul Sherje β-Cyclodextrin Nanosponges for Oral Drug Delivery of Anti-Hypertensive Drug Medical Sciences Forum β-cyclodextrin nanosponges antihypertensive solubility |
| title | β-Cyclodextrin Nanosponges for Oral Drug Delivery of Anti-Hypertensive Drug |
| title_full | β-Cyclodextrin Nanosponges for Oral Drug Delivery of Anti-Hypertensive Drug |
| title_fullStr | β-Cyclodextrin Nanosponges for Oral Drug Delivery of Anti-Hypertensive Drug |
| title_full_unstemmed | β-Cyclodextrin Nanosponges for Oral Drug Delivery of Anti-Hypertensive Drug |
| title_short | β-Cyclodextrin Nanosponges for Oral Drug Delivery of Anti-Hypertensive Drug |
| title_sort | β cyclodextrin nanosponges for oral drug delivery of anti hypertensive drug |
| topic | β-cyclodextrin nanosponges antihypertensive solubility |
| url | https://www.mdpi.com/2673-9992/14/1/41 |
| work_keys_str_mv | AT ritikaprashantkhivansara bcyclodextrinnanospongesfororaldrugdeliveryofantihypertensivedrug AT sandhyabajiraojadhav bcyclodextrinnanospongesfororaldrugdeliveryofantihypertensivedrug AT varshadaund bcyclodextrinnanospongesfororaldrugdeliveryofantihypertensivedrug AT atulsherje bcyclodextrinnanospongesfororaldrugdeliveryofantihypertensivedrug |